Methotrexate exposure prior to and during pregnancy.
Donnenfeld
A E
AE
Pastuszak
A
A
Noah
J S
JS
Schick
B
B
Rose
N C
NC
Koren
G
G
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000022:Abortion, Spontaneous; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003625:Data Collection; D005260:Female; D005306:Fertilization; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009436:Neural Tube Defects / Q000139:chemically induced*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy; D011256:Pregnancy Outcome; D011446:Prospective Studies; D013997:Time Factors
D005493:Folic Acid Antagonists; D008727:Methotrexate